# Talos Energy Inc.: financial statements, quarterly

TALO · NYSE · CIK 1724965 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/talo.md) · [Financials](/companies/talo/financials.md) · [Filings](/companies/talo/filings.md) · [Insiders](/companies/talo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/talo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [383](/filings/0000950170-24-125580.md) | [385 d](/filings/0001193125-26-067807.md) | [430](/filings/0000950170-25-063785.md) | [549](/filings/0000950170-25-104296.md) | [509](/filings/0001193125-25-267455.md) | [485 d](/filings/0001193125-26-067807.md) | [513](/filings/0001193125-26-207039.md) | [425](/filings/0001193125-26-333290.md) | [450](/filings/0001193125-25-267455.md) | [392 d](/filings/0001193125-26-067807.md) | [472](/filings/0001193125-26-207039.md) | [665](/filings/0001193125-26-333290.md) |
| Operating income | $m | [127](/filings/0000950170-24-125580.md) | [34.7 d](/filings/0001193125-26-067807.md) | [67.8](/filings/0000950170-25-063785.md) | [54.4](/filings/0000950170-25-104296.md) | [23.5](/filings/0001193125-25-267455.md) | [27.2 d](/filings/0001193125-26-067807.md) | [43.5](/filings/0001193125-26-207039.md) | [(274)](/filings/0001193125-26-333290.md) | [(86.2)](/filings/0001193125-25-267455.md) | [(244) d](/filings/0001193125-26-067807.md) | [(119)](/filings/0001193125-26-207039.md) | [198](/filings/0001193125-26-333290.md) |
| Interest expense | $m | [45.6](/filings/0000950170-24-125580.md) | [44.3 d](/filings/0001193125-26-067807.md) | [50.8](/filings/0000950170-25-063785.md) | [49.0](/filings/0000950170-25-104296.md) | [46.3](/filings/0001193125-25-267455.md) | [41.5 d](/filings/0001193125-26-067807.md) | [40.9](/filings/0001193125-26-207039.md) | [40.8](/filings/0001193125-26-333290.md) | [40.8](/filings/0001193125-25-267455.md) | [40.8 d](/filings/0001193125-26-067807.md) | [39.2](/filings/0001193125-26-207039.md) | [39.2](/filings/0001193125-26-333290.md) |
| Income tax | $m | [(15.9)](/filings/0000950170-24-125580.md) | [(5.1) d](/filings/0001193125-26-067807.md) | [(21.6)](/filings/0000950170-25-063785.md) | [(1.0)](/filings/0000950170-25-104296.md) | [18.1](/filings/0001193125-25-267455.md) | [9.4 d](/filings/0001193125-26-067807.md) | [(0.1)](/filings/0001193125-26-207039.md) | [(36.4)](/filings/0001193125-26-333290.md) | [(24.2)](/filings/0001193125-25-267455.md) | [(48.4) d](/filings/0001193125-26-067807.md) | [(65.3)](/filings/0001193125-26-207039.md) | [44.8](/filings/0001193125-26-333290.md) |
| Net income | $m | [(2.1)](/filings/0000950170-24-125580.md) | [85.9 d](/filings/0001193125-26-067807.md) | [(112)](/filings/0000950170-25-063785.md) | [12.4](/filings/0000950170-25-104296.md) | [88.2](/filings/0001193125-25-267455.md) | [(64.5) d](/filings/0001193125-26-067807.md) | [(9.9)](/filings/0001193125-26-207039.md) | [(186)](/filings/0001193125-26-333290.md) | [(95.9)](/filings/0001193125-25-267455.md) | [(203) d](/filings/0001193125-26-067807.md) | [(256)](/filings/0001193125-26-207039.md) | [150](/filings/0001193125-26-333290.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0000950170-24-125580.md) | not reported | [(0.71)](/filings/0000950170-25-063785.md) | [0.07](/filings/0000950170-25-104296.md) | [0.49](/filings/0001193125-25-267455.md) | not reported | [(0.05)](/filings/0001193125-26-207039.md) | [(1.05)](/filings/0001193125-26-333290.md) | [(0.55)](/filings/0001193125-25-267455.md) | not reported | [(1.52)](/filings/0001193125-26-207039.md) | [0.88](/filings/0001193125-26-333290.md) |
| Basic EPS | $ per share | [(0.02)](/filings/0000950170-24-125580.md) | not reported | [(0.71)](/filings/0000950170-25-063785.md) | [0.07](/filings/0000950170-25-104296.md) | [0.49](/filings/0001193125-25-267455.md) | not reported | [(0.05)](/filings/0001193125-26-207039.md) | [(1.05)](/filings/0001193125-26-333290.md) | [(0.55)](/filings/0001193125-25-267455.md) | not reported | [(1.52)](/filings/0001193125-26-207039.md) | [0.90](/filings/0001193125-26-333290.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [13.6](/filings/0000950170-23-059561.md) | [33.6](/filings/0000950170-25-028223.md) | [21.0](/filings/0000950170-24-053731.md) | [37.8](/filings/0000950170-24-093063.md) | [45.5](/filings/0000950170-24-125580.md) | [108](/filings/0001193125-26-067807.md) | [203](/filings/0000950170-25-063785.md) | [357](/filings/0000950170-25-104296.md) | [333](/filings/0001193125-25-267455.md) | [363](/filings/0001193125-26-333290.md) | [386](/filings/0001193125-26-207039.md) | [578](/filings/0001193125-26-333290.md) |
| Current assets | $m | [412](/filings/0000950170-23-059561.md) | [422](/filings/0000950170-25-028223.md) | [541](/filings/0000950170-24-053731.md) | [566](/filings/0000950170-24-093063.md) | [656](/filings/0000950170-24-125580.md) | [659](/filings/0001193125-26-067807.md) | [709](/filings/0000950170-25-063785.md) | [871](/filings/0000950170-25-104296.md) | [811](/filings/0001193125-25-267455.md) | [841](/filings/0001193125-26-333290.md) | [847](/filings/0001193125-26-207039.md) | [1,096](/filings/0001193125-26-333290.md) |
| Total assets | $m | [4,753](/filings/0000950170-23-059561.md) | [4,816](/filings/0000950170-25-028223.md) | [6,434](/filings/0000950170-24-053731.md) | [6,362](/filings/0000950170-24-093063.md) | [6,399](/filings/0000950170-24-125580.md) | [6,192](/filings/0001193125-26-067807.md) | [6,133](/filings/0000950170-25-063785.md) | [5,925](/filings/0000950170-25-104296.md) | [5,699](/filings/0001193125-25-267455.md) | [5,552](/filings/0001193125-26-333290.md) | [5,273](/filings/0001193125-26-207039.md) | [5,433](/filings/0001193125-26-333290.md) |
| Current liabilities | $m | [630](/filings/0000950170-23-059561.md) | [579](/filings/0000950170-25-028223.md) | [697](/filings/0000950170-24-053731.md) | [712](/filings/0000950170-24-093063.md) | [678](/filings/0000950170-24-125580.md) | [723](/filings/0001193125-26-067807.md) | [673](/filings/0000950170-25-063785.md) | [712](/filings/0000950170-25-104296.md) | [637](/filings/0001193125-25-267455.md) | [645](/filings/0001193125-26-333290.md) | [707](/filings/0001193125-26-207039.md) | [679](/filings/0001193125-26-333290.md) |
| Total liabilities | $m | [2,691](/filings/0000950170-23-059561.md) | [2,661](/filings/0000950170-25-028223.md) | [3,682](/filings/0000950170-24-053731.md) | [3,636](/filings/0000950170-24-093063.md) | [3,581](/filings/0000950170-24-125580.md) | [3,432](/filings/0001193125-26-067807.md) | [3,401](/filings/0000950170-25-063785.md) | [3,406](/filings/0000950170-25-104296.md) | [3,318](/filings/0001193125-25-267455.md) | [3,384](/filings/0001193125-26-333290.md) | [3,398](/filings/0001193125-26-207039.md) | [3,400](/filings/0001193125-26-333290.md) |
| Long-term debt | $m | [1,019](/filings/0000950170-23-059561.md) | [993](/filings/0000950170-25-028223.md) | [1,534](/filings/0000950170-24-053731.md) | [1,436](/filings/0000950170-24-093063.md) | [1,338](/filings/0000950170-24-125580.md) | [1,221](/filings/0001193125-26-067807.md) | [1,223](/filings/0000950170-25-063785.md) | [1,224](/filings/0000950170-25-104296.md) | [1,225](/filings/0001193125-25-267455.md) | [1,226](/filings/0001193125-26-333290.md) | [1,227](/filings/0001193125-26-207039.md) | [1,229](/filings/0001193125-26-333290.md) |
| Current portion of debt | $m | [33.1](/filings/0000950170-23-059561.md) | [33.1](/filings/0000950170-25-028223.md) | [0.0](/filings/0000950170-24-053731.md) | [0.0](/filings/0000950170-24-093063.md) | [0.0](/filings/0000950170-24-125580.md) | [0.0](/filings/0000950170-25-028223.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,062](/filings/0000950170-24-125580.md) | [2,155](/filings/0001193125-26-067807.md) | [2,752](/filings/0000950170-25-104296.md) | [2,726](/filings/0001193125-25-267455.md) | [2,818](/filings/0001193125-25-267455.md) | [2,760](/filings/0001193125-26-333290.md) | [2,731](/filings/0001193125-26-333290.md) | [2,519](/filings/0001193125-26-333290.md) | [2,380](/filings/0001193125-25-267455.md) | [2,168](/filings/0001193125-26-333290.md) | [1,875](/filings/0001193125-26-207039.md) | [2,033](/filings/0001193125-26-333290.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [65.7 d](/filings/0000950170-24-125580.md) | [176 d](/filings/0001193125-26-067807.md) | [96.4](/filings/0000950170-25-063785.md) | [289 d](/filings/0000950170-25-104296.md) | [227 d](/filings/0001193125-25-267455.md) | [349 d](/filings/0001193125-26-067807.md) | [268](/filings/0001193125-26-207039.md) | [352 d](/filings/0001193125-26-333290.md) | [114 d](/filings/0001193125-25-267455.md) | [202 d](/filings/0001193125-26-067807.md) | [174](/filings/0001193125-26-207039.md) | [301 d](/filings/0001193125-26-333290.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-125580.md) | [0.0 d](/filings/0001193125-26-067807.md) | [0.0](/filings/0000950170-25-063785.md) | [39.3 d](/filings/0000950170-25-104296.md) | [5.9 d](/filings/0001193125-25-267455.md) | [0.0 d](/filings/0001193125-26-067807.md) | [17.3](/filings/0001193125-26-207039.md) | [37.4 d](/filings/0001193125-26-333290.md) | [48.3 d](/filings/0001193125-25-267455.md) | [16.5 d](/filings/0001193125-26-067807.md) | [38.2](/filings/0001193125-26-207039.md) | [0.0 d](/filings/0001193125-26-333290.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [83.8](/filings/0000950170-23-059561.md) | [107](/filings/0000950170-24-053731.md) | [126](/filings/0000950170-24-093063.md) | [124](/filings/0000950170-24-125580.md) | [158](/filings/0000950170-25-063785.md) | [184](/filings/0000950170-25-104296.md) | [181](/filings/0001193125-25-267455.md) | [180](/filings/0001193125-26-207039.md) | [177](/filings/0001193125-26-333290.md) | [173](/filings/0001193125-25-267455.md) | [168](/filings/0001193125-26-207039.md) | [170](/filings/0001193125-26-333290.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 166,965,468 at 2026-07-28, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-333290.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.